NO306448B1 - Suppositorium for rektal administrering - Google Patents

Suppositorium for rektal administrering

Info

Publication number
NO306448B1
NO306448B1 NO954783A NO954783A NO306448B1 NO 306448 B1 NO306448 B1 NO 306448B1 NO 954783 A NO954783 A NO 954783A NO 954783 A NO954783 A NO 954783A NO 306448 B1 NO306448 B1 NO 306448B1
Authority
NO
Norway
Prior art keywords
rectal administration
administration suppository
suppository
rectal
administration
Prior art date
Application number
NO954783A
Other languages
English (en)
Norwegian (no)
Other versions
NO954783L (no
NO954783D0 (no
Inventor
Isabelle Thielemans
Isabelle Richard
Original Assignee
Glaxo Wellcome Sa Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Sa Lab filed Critical Glaxo Wellcome Sa Lab
Publication of NO954783L publication Critical patent/NO954783L/no
Publication of NO954783D0 publication Critical patent/NO954783D0/no
Publication of NO306448B1 publication Critical patent/NO306448B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
NO954783A 1993-05-25 1995-11-24 Suppositorium for rektal administrering NO306448B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939310756A GB9310756D0 (en) 1993-05-25 1993-05-25 Compositions
PCT/EP1994/001652 WO1994027599A1 (fr) 1993-05-25 1994-05-24 Compositions a administration par voie rectale

Publications (3)

Publication Number Publication Date
NO954783L NO954783L (no) 1995-11-24
NO954783D0 NO954783D0 (no) 1995-11-24
NO306448B1 true NO306448B1 (no) 1999-11-08

Family

ID=10736089

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954783A NO306448B1 (no) 1993-05-25 1995-11-24 Suppositorium for rektal administrering

Country Status (38)

Country Link
US (1) US5741806A (fr)
EP (1) EP0700290B1 (fr)
JP (1) JP2965703B2 (fr)
KR (1) KR100297212B1 (fr)
CN (1) CN1106194C (fr)
AP (1) AP544A (fr)
AT (1) ATE183643T1 (fr)
AU (1) AU680918B2 (fr)
BE (1) BE1007158A3 (fr)
BR (1) BR1100046A (fr)
CA (1) CA2162919C (fr)
CO (1) CO4230094A1 (fr)
CY (1) CY2411B1 (fr)
CZ (1) CZ291041B6 (fr)
DE (1) DE69420266T2 (fr)
DK (1) DK0700290T3 (fr)
EC (1) ECSP941088A (fr)
ES (1) ES2136198T3 (fr)
FR (1) FR2705569B1 (fr)
GB (2) GB9310756D0 (fr)
GR (1) GR3031669T3 (fr)
HR (2) HRP940315B1 (fr)
HU (1) HU227121B1 (fr)
IE (1) IE80632B1 (fr)
IL (1) IL109749A (fr)
IS (1) IS1868B (fr)
IT (1) IT1272990B (fr)
MY (1) MY111445A (fr)
NO (1) NO306448B1 (fr)
NZ (1) NZ267415A (fr)
PE (1) PE13395A1 (fr)
PL (1) PL175578B1 (fr)
RU (1) RU2132684C1 (fr)
SA (1) SA94150003B1 (fr)
SG (1) SG48119A1 (fr)
SI (1) SI0700290T1 (fr)
WO (1) WO1994027599A1 (fr)
ZA (1) ZA943593B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1464333A3 (fr) * 1998-06-15 2004-12-15 Sepracor Inc. Procedes permettant de traiter l'apnee, la boulimie et d'autres troubles au moyen du norcisapride (-) optiquement pur
EP1468685A3 (fr) * 1998-06-15 2004-12-15 Sepracor Inc. Procedes permettant de traiter l'apnee, la boulimie et d'autres troubles au moyen du norcisapride (+) optiquement pur
SK19062000A3 (sk) * 1998-06-15 2001-07-10 Sepracor, Inc. Použitie (-)-norcisapridu alebo jeho farmaceuticky prijateľnej soli, v podstate bez jeho (+) stereoizoméru, na liečenie apnoe, bulímie a iných porúch
BR9911299A (pt) * 1998-06-15 2001-03-13 Sepracor Inc Processos para tratar bulimia, para tratar distúrbios mediados por atividade vagal, para tratar sìndrome de intestino irritável, para tratar bradicardia ou bradiarritmia, para tratar asma, para tratar incontinência urinária, para tratar apnéia ou distúrbios de apnéia,ou distúrbios de apnéia, para prevenir ou controlar bulimia, distúrbios mediados por atividade vagal, sìndrome de intestino irritável, bradicardia ou bradiarritmia, asma, incontinência urinária, e, apnéia ou distúrbios da apnéia, em um paciente
US6362202B1 (en) 1999-03-02 2002-03-26 Sepracor Inc. Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
US6353005B1 (en) 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
BR0112969A (pt) * 2000-08-04 2004-06-22 Dmi Biosciences Inc Método de utilização de dicetopiperazinas e composições contendo-as

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
DE3502508A1 (de) * 1984-01-25 1985-08-14 Glaxo Group Ltd., London Heterocyclische verbindungen
GB8627909D0 (en) * 1986-11-21 1986-12-31 Glaxo Group Ltd Medicaments
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy

Also Published As

Publication number Publication date
ATE183643T1 (de) 1999-09-15
IE940420A1 (en) 1994-11-30
JPH08510457A (ja) 1996-11-05
SG48119A1 (en) 1998-04-17
PE13395A1 (es) 1995-05-25
IS4168A (is) 1994-11-26
GB2279008B (en) 1997-06-18
MY111445A (en) 2000-05-31
CY2411B1 (en) 2004-11-12
CN1106194C (zh) 2003-04-23
BE1007158A3 (fr) 1995-04-11
HRP940315B1 (en) 2000-12-31
AP9400643A0 (en) 1994-07-31
CZ308595A3 (en) 1996-06-12
CZ291041B6 (cs) 2002-12-11
NO954783L (no) 1995-11-24
SI0700290T1 (en) 1999-12-31
FR2705569B1 (fr) 1995-11-10
DE69420266D1 (de) 1999-09-30
IT1272990B (it) 1997-07-01
ECSP941088A (es) 1994-11-16
US5741806A (en) 1998-04-21
AP544A (en) 1996-10-11
CO4230094A1 (es) 1995-10-19
EP0700290A1 (fr) 1996-03-13
RU2132684C1 (ru) 1999-07-10
AU6970994A (en) 1994-12-20
EP0700290B1 (fr) 1999-08-25
ITRM940322A0 (it) 1994-05-24
GB9409835D0 (en) 1994-07-06
GB9310756D0 (en) 1993-07-14
HUT74867A (en) 1997-02-28
FR2705569A1 (fr) 1994-12-02
PL311721A1 (en) 1996-03-04
ZA943593B (en) 1995-02-13
BR1100046A (pt) 1999-11-23
IS1868B (is) 2003-05-02
AU680918B2 (en) 1997-08-14
IL109749A (en) 1999-03-12
GB2279008A (en) 1994-12-21
JP2965703B2 (ja) 1999-10-18
HRP940315A2 (en) 1996-08-31
DE69420266T2 (de) 1999-12-09
NZ267415A (en) 1997-10-24
CN1124454A (zh) 1996-06-12
IL109749A0 (en) 1994-08-26
PL175578B1 (pl) 1999-01-29
HU227121B1 (en) 2010-07-28
IE80632B1 (en) 1998-10-21
ITRM940322A1 (it) 1995-11-24
NO954783D0 (no) 1995-11-24
CA2162919A1 (fr) 1994-12-08
CA2162919C (fr) 1999-07-20
SA94150003B1 (ar) 2005-04-11
HU9503375D0 (en) 1996-01-29
KR100297212B1 (ko) 2001-10-24
HRP970315A2 (en) 1999-04-30
ES2136198T3 (es) 1999-11-16
GR3031669T3 (en) 2000-02-29
DK0700290T3 (da) 2000-03-13
WO1994027599A1 (fr) 1994-12-08

Similar Documents

Publication Publication Date Title
DE59409564D1 (de) Kühlflüssigkeitsleitung
DE69425492D1 (de) Rektalsonde
DE59408767D1 (de) Kühlflüssigkeitsleitung
FI932741A0 (fi) Mjukvaevnadsfilteranordning till kefalostat
ES1021151Y (es) Supositorio
FI933834A0 (fi) Polsko till en magnetografisk avbildningsapparat
NO306448B1 (no) Suppositorium for rektal administrering
NO933444D0 (no) Linearrangement
DK121592D0 (da) Suppositorium
DK0617221T3 (da) Rørforbindelse
DE69422212D1 (de) Unterbrechungsanordnung
DK0627590T3 (da) Rørforbindelse
KR950013034U (ko) 담배 파이프
KR950016748U (ko) 관장기구
KR950016749U (ko) 관장기구
SE9302668D0 (sv) Enslinjen
KR940016029U (ko) 암거의 하부판
FI769U1 (fi) Tillaeggsanordning till sparkstoetting
FI1025U1 (fi) Stampenhet till asfalteringsmaskin
FI944U1 (fi) Paobyggnadssidor till en skottkaerra
FI914U1 (fi) Tillaeggsanordning till skottkaerra
FI910U1 (fi) Spetsdel till fiskeredskap
FI919U1 (fi) Skakel till dragackja
FI1250U1 (fi) Doerrar till skyddsrum
LT2470B (lt) Ultragarsinis atstumo matuoklis

Legal Events

Date Code Title Description
MK1K Patent expired